Clinical trial
Comparison of Six-Month Functional Outcomes Following Anterior Cruciate Ligament (ACL) Reconstruction Using Peroneus Longus Tendon Grafts With Adjunctive Secretome Injection Versus Without Secretome Injection
NCT07723625 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Six-Month Functional Outcomes Following Anterior Cruciate Ligament (ACL) Reconstruction Using Peroneus Longus Tendon Grafts With Adjunctive Secretome Injection Versus Without Secretome Injection
- Lead sponsor
- PT. Prodia Stem Cell Indonesia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 14, 2025
- Completion date
- July 1, 2026
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acl injury, acl tear